Added to YB: 2025-02-05
Pitch date: 2024-12-20
LNSR [bullish]
LENSAR, Inc.
-22.7%
current return
Author Info
No bio for this author
Company Info
LENSAR, Inc., a commercial-stage medical device company, focuses on designing, developing, and marketing laser systems for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism in the United System, Europe, Asia, South Korea, and internationally.
Market Cap
$72.1M
Pitch Price
$7.84
Price Target
46.20 (+662%)
Dividend
N/A
EV/EBITDA
-3.65
P/E
-2.08
EV/Sales
1.21
Sector
Health Care Equipment and Supplies
Category
growth
LENSAR, Inc. - $LNSR
LNSR: Fast-growing (20-30%) cataract laser system co. trading at 2x EV/fwd rev. High GM (80-85%) on recurring revenue. New ALLY system taking share from ALC/JNU. Potential for 3-6x return in 3 years on growth, margin expansion, and multiple re-rating. Acquisition target for ALC/JNU. Catalysts: Q4 financials, continued growth.
Read full article (12 min)